EPISODE · Apr 25, 2026 · 1 MIN
NeoGenomics' Epic Move in Oncology Testing
from The Daily News Now! Business
NeoGenomics stock surged 4.1% after announcing its oncology tests are now available on the Epic Aura platform, streamlining diagnostics for hospitals. This move is part of NeoGenomics digital health push, aiming to boost test orders. Despite mixed earnings and a volatile stock, traders see this as solid progress. The companys long-term performance has been lackluster, but this Epic integration could help NeoGenomics build momentum in the competitive oncology market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8d2f49780130ac5a
NOW PLAYING
NeoGenomics' Epic Move in Oncology Testing
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m